Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

140 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Role of oxaliplatin in the treatment of colorectal cancer.
Comella P, Casaretti R, Sandomenico C, Avallone A, Franco L. Comella P, et al. Ther Clin Risk Manag. 2009 Feb;5(1):229-38. doi: 10.2147/tcrm.s3583. Epub 2009 Mar 26. Ther Clin Risk Manag. 2009. PMID: 19436599 Free PMC article.
Optimizing the management of metastatic colorectal cancer.
Comella P, Casaretti R, Avallone A, Franco L. Comella P, et al. Crit Rev Oncol Hematol. 2010 Jul;75(1):15-26. doi: 10.1016/j.critrevonc.2009.09.008. Epub 2009 Oct 17. Crit Rev Oncol Hematol. 2010. PMID: 19837601 Review.
A tailored regimen including capecitabine and oxaliplatin for treating elderly patients with metastatic colorectal carcinoma Southern Italy Cooperative Oncology Group trial 0108.
Comella P, Gambardella A, Farris A, Maiorino L, Natale D, Massidda B, Casaretti R, Tafuto S, Lorusso V, Leo S; Southern Italy Cooperative Oncology Group. Comella P, et al. Crit Rev Oncol Hematol. 2005 Feb;53(2):133-9. doi: 10.1016/j.critrevonc.2004.10.008. Crit Rev Oncol Hematol. 2005. PMID: 15661564 Clinical Trial.
Randomised trial comparing biweekly oxaliplatin plus oral capecitabine versus oxaliplatin plus i.v. bolus fluorouracil/leucovorin in metastatic colorectal cancer patients: results of the Southern Italy Cooperative Oncology study 0401.
Comella P, Massidda B, Filippelli G, Farris A, Natale D, Barberis G, Maiorino L, Palmeri S, Cannone M, Condemi G; Southern Italy Cooperative Oncology Group. Comella P, et al. J Cancer Res Clin Oncol. 2009 Feb;135(2):217-26. doi: 10.1007/s00432-008-0454-7. Epub 2008 Aug 22. J Cancer Res Clin Oncol. 2009. PMID: 18719941 Clinical Trial.
Oxaliplatin, irinotecan, and fluorouracil/folinic acid in advanced gastric cancer: a multicenter phase II trial of the Southern Italy Cooperative Oncology Group.
Comella P, Lorusso V, Maiorino L, Casaretti R, Cannone M, Massidda B, Putzu C, Leo S, Roselli M, Mancarella S, Palmeri S, Greco E, Vessia G, Sandomenico C, Franco L. Comella P, et al. Cancer Chemother Pharmacol. 2009 Oct;64(5):893-9. doi: 10.1007/s00280-009-0938-4. Epub 2009 Feb 3. Cancer Chemother Pharmacol. 2009. PMID: 19189106 Free article. Clinical Trial.
Emerging role of capecitabine in gastric cancer.
Comella P, Franco L, Casaretti R, de Portu S, Menditto E. Comella P, et al. Pharmacotherapy. 2009 Mar;29(3):318-30. doi: 10.1592/phco.29.3.318. Pharmacotherapy. 2009. PMID: 19249950 Review.
140 results